What is NDC 16571-856?

16571-856 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Rising Pharma Holdings, Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.

Rising Pharma Holdings, Inc., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pentoxifylline?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pentoxifylline NDC 16571-856 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)16571-856Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16571-0856Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
16571-856-01	16571085601	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01)Marketed from Jun 5, 2026
16571-856-05	16571085605	50 BLISTER PACK in 1 CARTON (16571-856-05) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Jun 5, 2026
16571-856-11	16571085611	10 BLISTER PACK in 1 CARTON (16571-856-11) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Jun 5, 2026
16571-856-50	16571085650	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50)Marketed from Jun 5, 2026
16571-856-90	16571085690	1 BLISTER PACK in 1 CARTON (16571-856-90) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Jun 5, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pentoxifylline
Generic name (nonproprietary): pentoxifylline
Active ingredients: Pentoxifylline — 400 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 16571
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074425
Marketing start: Jun 11, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Hematologic Activity Alteration (Physiologic effect)
Identifiers: Product ID 16571-856_465e591b-4af7-4b59-a076-73bc26758edaSPL ID 465e591b-4af7-4b59-a076-73bc26758edaSPL set ID cd840a2c-2a0e-4b2b-84ff-a0406bb6fa37RxCUI 312301UNII SD6QCT3TSUUPC 0316571856503
Pharmacologic class: Blood Viscosity Reducer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416571085601 followed by a unit qualifier and the quantity

Package 16571-0856-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 15, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline extended-release tablets can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 16571-856

What is NDC 16571-856?: 16571-856 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Rising Pharma Holdings, Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pentoxifylline.
What is the active ingredient?: Pentoxifylline.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pentoxifylline?: 7 other product NDCs are listed under this name. See all Pentoxifylline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pentoxifylline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Pentoxifylline	Pentoxifylline 400 mg/1	TabletOral	Advagen Pharma Ltd.,	72888-268	72888-0268-0172888-0268-0272888-0268-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-2586	71335-2586-0171335-2586-0271335-2586-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8511	00615-8511-39
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	ANI Pharmaceuticals, Inc.	70954-668	70954-0668-1070954-0668-20
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Major Pharmaceuticals	0904-5448	00904-5448-61
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-2910	63629-2910-0163629-2910-0263629-2910-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Apotex Corp.	60505-0033	60505-0033-0660505-0033-07

Other NDCs under ANDA 074425

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074425
Product	Strength	Form · route	Labeler	Product NDC
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-2586